NCT01827904: A trial that was reported late by InSightec
This trial has reported, although it was 38 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01827904 |
|---|---|
| Title | A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | May 31, 2013 |
| Completion date | Dec. 31, 2022 |
| Required reporting date | Dec. 31, 2023, midnight |
| Actual reporting date | Oct. 4, 2023 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | 38 |